Endocannabinoid system and opioid addiction: behavioural aspects.
Cannabinoids produce a variety of pharmacological effects very similar to those elicited by opioids. Direct and indirect interactions with opioid system have been proposed to explain some cannabinoid effects such as analgesia and attenuation of opioid-withdrawal syndrome, and evidence has been provided in support to the notion that rewarding properties of cannabinoids and opioids might be functionally linked. In particular, a growing body of studies points to an important role of the endogenous cannabinoid system in the modulation of opioid rewarding and addictive effects. The current review examines progresses in the past few years in the elucidation of cannabinoid-opioid interactions in drug abuse and dependence, focusing on recent findings from behavioural studies using different animal models of addiction. Specifically, here we review data on the behavioural aspects (i.e., drug abuse, dependence, tolerance, sensitization, relapse and drug vulnerability) of the specific, often reciprocal, cross-talk between cannabinoids and opioids with particular reference to the role of the endocannabinoid system in opioid addiction. The potential biochemical mechanisms involved in these pharmacological interactions are discussed together with possible therapeutic implications in the pharmacotherapy of opioid dependence. However, individuation of the precise anatomical substrates and molecular mechanisms of such interaction still remains a complex and challenging field for future research.
Fattore
Liana
L
Institute of Neuroscience, National Research Council CNR, Section of Cagliari, Italy.
Deiana
Serena
S
Spano
Sabrina M
SM
Cossu
Gregorio
G
Fadda
Paola
P
Scherma
Maria
M
Fratta
Walter
W
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D063385:Cannabinoid Receptor Modulators / Q000502:physiology*; D004361:Drug Tolerance; D063388:Endocannabinoids; D006801:Humans; D009293:Opioid-Related Disorders / Q000503:physiopathology* / Q000523:psychology*; D012201:Reward; D012646:Self Administration; D012653:Self Stimulation
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids